Rates of surgical site infections and length of stay following major gynecologic oncology surgery for patients on federally funded insurance: A 6-month retrospective cohort.

Phase 1 trial of GD2-SADA: 177 Lu-DOTA drug complex in patients with recurrent or refractory metastatic solid tumors known to express GD2 including small cell lung cancer (SCLC), sarcoma, and ...

Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.

Therapeutic effect of gedatolisib, a pan-PI3K/mTOR inhibitor, on prostate cancer models with PI3K or PTEN mutational status.

Ancillary Educational Events are not official events of the 2024 ASCO® Annual Meeting and are not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, CancerLinQ® , or ...

We want you to have the best meeting experience possible. To help you navigate the meeting and engage with presenters and content, we have prepared the below overview. You can visit the online program ...

Learn more about abstract submission, policies, and guidelines for faculty and presenters.

All MOC point requests and CE credit claims must be submitted by September 4, 2025. Credit claiming will not be available after this date. A pop-up will display to guide you through logging credit for ...

ASCO recognizes the importance of bringing together researchers to discuss ongoing trials. Trials in Progress posters provide an opportunity for members of the research community to present ongoing ...

The 2025 ASCO Annual Meeting is The Place to Be—a global gathering where oncology professionals connect, collaborate, and inspire. Known for advancing the field, this must-attend event offers an ...

The ASCO scientific program committee looks forward to reviewing abstracts in the following categories. Authors are asked to select a track and subcategory when submitting their abstract.

Fellows submitting high-quality abstracts, as well as oncologists from countries with limited resources, are eligible for awards for the Annual Meeting. These awards are offered through Conquer Cancer ...